1-10 of 43 results

Down-scheduling CBD and growing Australia's cannabis industry
Insight 10 Nov 2020

The Therapeutics Goods Administration is proposing amendments to the Poisons Standard to permit pharmacists to sell low-dose cannabidiol (CBD) products without a prescription. Businesses intending to import, manufacture and supply cannabis products in the Australian market should monitor these developments closely. ...

UK Supreme Court affirms jurisdiction to determine global FRAND terms
Insight 07 Sep 2020

The UK Supreme Court's decision in Unwired Planet v Huawei confirms that disputes between organisations that own these patents, and equipment manufacturers that use the patents, can be brought and resolved on a worldwide basis in England. ...

Changes ongoing for product liability and compliance during COVID-19
Insight 07 Aug 2020

Amidst increased scrutiny by the Therapeutic Goods Administration and the ACCC, Australian businesses which manufacture personal protective equipment (PPE), detergents and hand sanitiser must remain on top of changes to product laws in the healthcare space in order to avoid potential liability. ...

PBS process proving a headache for migraine medications
Insight 29 Jun 2020

Challenging a PBAC decision is not straightforward. We take a look at the available options and examine the alleged delays in listing migraine treatments Emgality and Ajovy on the PBS. ...

Linklaters Insights: Novel Coronavirus - practice guide of significant commercial and legal issues
Insight 17 Feb 2020

The recent outbreak of the novel coronavirus is causing disruption across greater China and the region. This cross-practice guide from our colleagues at Linklaters highlights key issues that may affect business operations in the current environment. ...

TGA guidance on the promotion of stem cells and HCT products
Insight 10 Dec 2019

The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...

Healthcare trend watch 2019
Insight 09 Dec 2019

The healthcare team at Allens reports on some key trends and sectors to look out for in 2020. ...

TGA guidance on the promotion of medicinal cannabis
Insight 25 Nov 2019

The Therapeutic Goods Administration ( TGA ) has issued guidance on advertising to the public for businesses involved with medicinal cannabis products and therapies. Along with advertising ...

3D printing legal workshop - a deeper dive
Insight 18 Dec 2018

The Allens 3D Printing Practice recently held a workshop in Melbourne and Sydney which explored key legal issues arising from 3D printing particularly for the healthcare industry Our Allens panel members - Sarah Matheson Ric Morgan Phil OSullivan Dr Tony Shaw Tracy Lu and Rob Munro - were joined by ...

Making sense of human cell and tissue products regulation
Insight 12 Sep 2018

The Therapeutic Goods Administration has released guidance on recent changes to the regulation of human cell and tissue products Special Counsel Ric Morgan and Senior Associate Tracy Lu dissect the complex regulatory framework particularly in relation to advertising ...

Refine

From
To